Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis;Adhesión al tratamiento, estado emocional y calidad de vida en pacientes con insuficiencia renal crónica en tratamiento con diálisis

Psicothema

Volumn 25, Issue 1, 2013, Pages 79-86

  García Llana, Helena ^a   Remor, Eduardo ^b   Selgas, Rafael ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adherence; Anxiety; Depression; Dialysis; Quality of life

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC KIDNEY FAILURE; DEPRESSION; EMOTION; FEMALE; HUMAN; MALE; MENTAL STRESS; MIDDLE AGED; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; EMOTIONS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84872825740     PISSN: 02149915     EISSN: None     Source Type: Journal    
DOI: 10.7334/psicothema2012.96     Document Type: Article

References (34)

1. Abdel-Kader, K., Unruh, M.L., & Weisbord, S.D. (2009). Sympton burden, depression and quality of life in chronic and end-stage kidney disease. Clinical Journal of the American Society of Nephrology, 4, 1057-1064.
2. Alonso, J., Prieto, L., & Antó, M. (1995). La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de resultados clínicos [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire: An instrument for measuring clinical results]. Medicina Clínica, 104(20), 771-776.
3. Alonso, J., Regidor, E., Barrio, G., Prieto, L., Rodríguez, C., & de la Fuente, L. (1998). Valores poblacionales de referencia de la version española del Cuestionario de Salud SF-36 [Population reference values of the Spanish version of the Health Questionnaire SF-36]. Medicina Clínica, 111, 410-416.
4. Arenas, M.D., Malek, T., Álvarez-Ude, M.T., Moledus, A., & Reig-Ferrer, A. (2010). Captores del fósforo: preferencias de los pacientes en hemodiálisis y su repercusión sobre el cumplimiento del tratamiento y el control del fósforo [Phosphorus binders: Preferences of patients on hemodialysis and its impact on treatment compliance and phosphorus control]. Nefrología, 30(5), 522-530.
5. Arenas, M.D., Malek, T., Gil, M.T., Moledous, A., Álvarez-Ude, F., & Reig-Ferrer, A. (2010). Challenge of phosphorous control in hemodialysis patients. A problem of adherence? Journal of Nephrology, 23(5), 525-534.
6. Beck, A.T., Steer, R.A., & Brown, G.K. (1996). BDI-II. Beck Depression Inventory. Second Edition Manual. San Antonio, TX: The Psychological Corporation.
7. Boateng, E.A., & East, L. (2011). The impact of dialysis modality on quality of life: A systematic review. Journal of Renal Care, 37(4), 190-200.
8. Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24, 386-396.
9. Cukor, D., Cohen, S.D., Peterson, R.A., & Kimmel, P.L (2007). Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness. Journal of the American Society of Nephrology, 18, 3042-3055.
10. Cukor, D., Rosenthal, D.S, Jindal, R.M., Brown, C.D., & Kimmel, P.L. (2009). Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney International, 75, 1223-1229.
11. Cvengros, J., Christensen, A., & Lawton, W. (2004). The role of perceived control and preference for control in adherence to chronic medical regimen. Annals of Behavioral Medicine, 27(3), 155-161.
12. Durose, C.L., Holdsworth, M., Watson, V., & Przygrodzka, F. (2004). Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. Journal of the American Dietetic Association, 1, 35-41.
13. Haynes, R.B., Taylor, D.W., & Sackett, D.L. (Eds.) (1979). Compliance in health care. Baltimore, MD: Johns Hopkins University Press.
14. Karamanidou, C., Clatworthy, J., Weinman, J., & Horne, R. (2008). A systematic review of the prevalence and determinants of non-adherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrology, 9(2). doi: 10.1186/1471-2369-9-2.
15. Maldaner, C.R., Beuter, M., Brondani, C.M., Budó, L., & Pauletto, M.R. (2008). Factors that influence treatment adherence in chronic disease patients undergoing hemodialysis. Revista Gaúcha de Enfermagem, 29(4), 647-653.
16. McHorney, C., Ware, J., & Raczeck, A. (1993). The MOS 36-item short-form health survey (SF-36). II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
17. Morales-Jaimes, R., Salazar-Martínez, E., Flores-Villegas, F.J., Bochicchio-Ricardelli, T., & López-Caudana, A. (2008). Calidad de vida relacionada con la salud en los pacientes con tratamiento sustitutivo renal: el papel de la depression [Health-related quality of life in patients with substitutive renal treatment: The role of depression]. Gaceta Médica Mexicana, 144(2), 91-98.
18. Morisky D.E., Green, L.W., & Levine D.M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67-74.
19. Moser, M., & Setaro, J.F. (2006). Resistant or difficult-to-control hypertension. New England Journal of Medicine, 355(4), 385-392.
20. Otero, A., de Francisco, A., Gayoso, P., García, F., & EPIRCE study group (2010). Prevalence of chronic renal disease in Spain: Results of the EPIRCE study. Nefrología, 30(1), 78-86.
21. Reach, G. (2008). A novel conceptual framework for understanding the mechanism of adherence to long term therapies. Patient Preference and Adherence, 2, 7-19.
22. Remor, E. (2002). Valoración de la adhesión al tratamiento antirretroviral en pacientes con VIH+ [Assessment of adherence to antiretroviral therapy in HIV+ patients]. Psicothema, 14(2), 262-267.
23. Remor, E. (2006). Psychometric properties of a European Spanish version of the Perceived Stress Scale. The Spanish Journal of Psychology, 9(1), 86-93.
24. Remor, E. (2011). Predictors of treatment difficulties and satisfaction with haemophilia therapy in adult patients. Haemophilia, 17, e901-e905.
25. Rodríguez-Fructuoso, M., Castro, R., Oliveira, I., Prata, C., & Morgado, T. (2011). Quality of life in chronic kidney disease. Nefrología, 31(1), 91-96.
26. Ross, E.A., Pittman, T.B., & Koo, L.C. (2002). Strategy for the treatment of noncompliant hypertensive hemodialysis patients. International Journal of Artificial Organs, 25(11), 1061-1065.
27. Ruiz de Alegría-Fernández de Retana, B., Basabe-Barañano, N., Fernández-Prado, E., Baños-Baños, C., Nogales-Rodríguez, M.A., Echavarri-Escribano, Díez de Valdeón Herrero, M.S. (2009). Calidad de vida y afrontamiento: diferencias entre los pacientes en diálisis peritoneal continua ambulatoria y hemodiálisis hospitalaria [Quality of life and coping: Differences between patients receiving continuous ambulatory peritoneal dialysisand those under hospital hemodialysis]. Enfermería Clínica, 19(2), 61-68.
28. Sanz, J., Perdigón, A.L., & Vázquez, C. (2003). Adaptación española del inventario para la depresión del Beck-II (BDI-II): 2. Propiedades psicométricas en población general [The Spanish adaptation of Beck's Depression Inventory II (BDI-II): 2. Psychometric properties in the general population]. Clínica y Salud, 14(3), 249-280.
29. Seisdedos, M. (1982). STAI. Cuestionario de ansiedad Estado-Rasgo [STAI-State-Trait Anxiety Inventory]. Madrid. TEA.
30. Spielberger, C.D., Gorsuch, R.L., & Lushene, R.E (1983). STAI. Manual for the State-Trait Anxiety Inventory. Consulting Psychology Press: Palo Alto California.
31. Tonelli, M., Pannu, N., & Manns, B. (2010). Oral phosphate binders in patients with kidney failure. New England Journal of Medicine, 362, 1312-1324.
32. Val-Jiménez, A., Amorós, G., Martínez, P., Fernández, M.L., & León, M. (1992). Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del Test Morisky y Green [Descriptive study on adherence over antihypertensive pharmacological treatment and validation of the Morisky Green Test]. Atención Primaria, 10, 767-770.
33. Varela, L., Vázquez, M.I., Bolaños, L., & Alonso, R. (2011). Predictores psicológicos de la calidad de vida relacionada con la salud en pacientes en tratamiento de diálisis peritoneal [Psychological predictors of health-related quality of life in patients on peritoneal dialysis]. Nefrología, 31(1), 97-106.
34. Walters, B.A.J., Hays, R.D., Spritzer, K.L., Fridman, M., & Carter, W.B. (2002). Health-related quality of life, depressive symptoms, anemia and malnutrition at hemodialysis initiation. American Journal of Kidney Diseases, 6, 1185-1194.